CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,026 | -69.4% | 309 | -56.4% | 0.01% | -70.0% |
Q2 2023 | $45,823 | +42.9% | 709 | 0.0% | 0.03% | +42.9% |
Q1 2023 | $32,068 | +11.3% | 709 | 0.0% | 0.02% | +5.0% |
Q4 2022 | $28,821 | -37.3% | 709 | 0.0% | 0.02% | -39.4% |
Q3 2022 | $46,000 | +7.0% | 709 | 0.0% | 0.03% | +13.8% |
Q2 2022 | $43,000 | -4.4% | 709 | 0.0% | 0.03% | +7.4% |
Q1 2022 | $45,000 | -16.7% | 709 | 0.0% | 0.03% | -12.9% |
Q4 2021 | $54,000 | -33.3% | 709 | -2.6% | 0.03% | -35.4% |
Q3 2021 | $81,000 | -31.4% | 728 | 0.0% | 0.05% | -30.4% |
Q2 2021 | $118,000 | +15.7% | 728 | -12.7% | 0.07% | +9.5% |
Q1 2021 | $102,000 | -11.3% | 834 | +11.5% | 0.06% | -18.2% |
Q4 2020 | $115,000 | +101.8% | 748 | +9.5% | 0.08% | +87.8% |
Q3 2020 | $57,000 | +14.0% | 683 | 0.0% | 0.04% | +7.9% |
Q2 2020 | $50,000 | +212.5% | 683 | +78.3% | 0.04% | +171.4% |
Q1 2020 | $16,000 | -30.4% | 383 | 0.0% | 0.01% | -12.5% |
Q4 2019 | $23,000 | +15.0% | 383 | -20.7% | 0.02% | +6.7% |
Q3 2019 | $20,000 | -4.8% | 483 | +6.2% | 0.02% | -6.2% |
Q2 2019 | $21,000 | +31.2% | 455 | 0.0% | 0.02% | +33.3% |
Q1 2019 | $16,000 | +1500.0% | 455 | +1416.7% | 0.01% | +1100.0% |
Q4 2018 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $1,000 | -50.0% | 30 | 0.0% | 0.00% | -50.0% |
Q2 2018 | $2,000 | +100.0% | 30 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $1,000 | 0.0% | 30 | -50.0% | 0.00% | 0.0% |
Q4 2017 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $1,000 | – | 60 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |